ClinConnect ClinConnect Logo
Search / Trial NCT06937138

Artificial Intelligence-Assisted vs Surgeon-Directed Screw Planning in Robotic Femoral Neck Fracture Surgery

Launched by WUHAN UNION HOSPITAL, CHINA · Apr 18, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Robotic Assisted Orthopedic Surgery Screw Placement Accuracy Artificial Intelligence In Surgical Planning

ClinConnect Summary

This clinical trial is studying two different ways to plan the placement of screws during robotic surgery for femoral neck fractures, which are common injuries in the hip area. One method uses guidance from artificial intelligence (AI), while the other relies on the surgeon's experience. The main goal is to find out if using AI can make the surgery more accurate, reduce the time it takes, lower the amount of blood lost during the procedure, and lead to better recovery outcomes compared to the traditional method.

To participate in this trial, individuals need to be at least 18 years old and have a confirmed femoral neck fracture that requires surgery with robotic assistance. They should also be able to understand the study and agree to participate. Participants will receive standard care and follow-up after surgery, and their progress will be monitored for six months through assessments and imaging tests. It's important to note that individuals with certain health issues or who cannot undergo surgery may not be eligible. This study aims to see if AI can truly enhance the precision and safety of these surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years;
  • Radiologically confirmed diagnosis of femoral neck fracture (displaced or non-displaced);
  • Scheduled to undergo robotic-assisted internal fixation with cannulated screws as the initial treatment strategy during the study period;
  • Capable of understanding the study procedures and providing informed consent;
  • Willing and able to adhere to the prescribed postoperative follow-up schedule and rehabilitation instructions.
  • Exclusion Criteria:
  • Evidence of avascular necrosis of the femoral head on the affected side prior to surgery;
  • Inability to tolerate the surgical intervention;
  • Severe physical illnesses, cognitive problems (such as memory loss), or mental health conditions that may impair the ability to comply with medical instructions or attending scheduled follow-up appointments.

About Wuhan Union Hospital, China

Wuhan Union Hospital, affiliated with Huazhong University of Science and Technology, is a leading medical institution located in Wuhan, China. Renowned for its comprehensive healthcare services and advanced research capabilities, the hospital plays a pivotal role in clinical trials aimed at enhancing medical knowledge and patient care. With a commitment to innovation and excellence, Wuhan Union Hospital collaborates with various stakeholders to conduct rigorous and ethically sound clinical research, contributing significantly to the advancement of medical science and public health both domestically and internationally.

Locations

Wuhan, Hubei, China

Patients applied

0 patients applied

Trial Officials

Guohui Liu, MD, PhD

Principal Investigator

Wuhan Union Hospital, China

Bobin Mi, MD, PhD

Principal Investigator

Wuhan Union Hospital, China

Fawwaz O. Al-Smadi, MD

Principal Investigator

Wuhan Union Hospital, China

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported